202 related articles for article (PubMed ID: 12372095)
1. Urinary N-methylhistamine as an indicator of bone marrow involvement in mastocytosis.
Oranje AP; Mulder PG; Heide R; Tank B; Riezebos P; van Toorenenbergen AW
Clin Exp Dermatol; 2002 Sep; 27(6):502-6. PubMed ID: 12372095
[TBL] [Abstract][Full Text] [Related]
2. Urinary 11β-PGF2α and N-methyl histamine correlate with bone marrow biopsy findings in mast cell disorders.
Divekar R; Butterfield J
Allergy; 2015 Oct; 70(10):1230-8. PubMed ID: 26095439
[TBL] [Abstract][Full Text] [Related]
3. A potential role for the mast cell in the pathogenesis of idiopathic osteoporosis in men.
Brumsen C; Papapoulos SE; Lentjes EG; Kluin PM; Hamdy NA
Bone; 2002 Nov; 31(5):556-61. PubMed ID: 12477568
[TBL] [Abstract][Full Text] [Related]
4. Comparison of serum tryptase and urine N-methylhistamine in patients with suspected mastocytosis.
van Toorenenbergen AW; Oranje AP
Clin Chim Acta; 2005 Sep; 359(1-2):72-7. PubMed ID: 15913591
[TBL] [Abstract][Full Text] [Related]
5. Value of urinary N-methylhistamine measurements in childhood mastocytosis.
Van Gysel D; Oranje AP; Vermeiden I; de Lijster de Raadt J; Mulder PG; van Toorenenbergen AW
J Am Acad Dermatol; 1996 Oct; 35(4):556-8. PubMed ID: 8859283
[TBL] [Abstract][Full Text] [Related]
6. Diminished reliability of tryptase as risk indicator of mastocytosis in older overweight subjects.
Vos BJ; van der Veer E; van Voorst Vader PC; Mulder AB; van der Heide S; Arends S; Kluin-Nelemans JC; de Monchy JG; van Doormaal JJ; Oude Elberink JN
J Allergy Clin Immunol; 2015 Mar; 135(3):792-8. PubMed ID: 25129675
[TBL] [Abstract][Full Text] [Related]
7. Diffuse cutaneous mastocytosis with bone marrow infiltration in a child: a case report.
Waxtein LM; Vega-Memije ME; Cortés-Franco R; Dominguez-Soto L
Pediatr Dermatol; 2000; 17(3):198-201. PubMed ID: 10886751
[TBL] [Abstract][Full Text] [Related]
8. Tryptase detection in bone-marrow blood: a new diagnostic tool in systemic mastocytosis.
Proelss J; Wenzel J; Ko Y; Bieber T; Bauer R
J Am Acad Dermatol; 2007 Mar; 56(3):453-7. PubMed ID: 17317486
[TBL] [Abstract][Full Text] [Related]
9. Hematologic manifestations of systemic mast cell disease: a prospective study of laboratory and morphologic features and their relation to prognosis.
Lawrence JB; Friedman BS; Travis WD; Chinchilli VM; Metcalfe DD; Gralnick HR
Am J Med; 1991 Dec; 91(6):612-24. PubMed ID: 1750431
[TBL] [Abstract][Full Text] [Related]
10. Establishing diagnostic criteria for mastocytosis in skin biopsies.
Drabent P; Polivka L; Agopian J; Duong Van Huyen JP; Thiebaut PA; Dubreuil P; Hermine O; Molina TJ; Fraitag S
Histopathology; 2022 Feb; 80(3):501-514. PubMed ID: 34637148
[TBL] [Abstract][Full Text] [Related]
11. The bone marrow in urticaria pigmentosa and systemic mastocytosis. Cell composition and mast cell density in relation to urinary excretion of tele-methylimidazoleacetic acid.
Ridell B; Olafsson JH; Roupe G; Swolin B; Granerus G; Rödjer S; Enerbäck L
Arch Dermatol; 1986 Apr; 122(4):422-7. PubMed ID: 3954410
[TBL] [Abstract][Full Text] [Related]
12. Mastocytosis: state of the art.
Horny HP; Sotlar K; Valent P
Pathobiology; 2007; 74(2):121-32. PubMed ID: 17587883
[TBL] [Abstract][Full Text] [Related]
13. Biochemical markers predictive for bone marrow involvement in systemic mastocytosis.
Donker ML; van Doormaal JJ; van Doormaal FF; Kluin PM; van der Veer E; de Monchy JG; Kema IP; Kluin-Nelemans HC
Haematologica; 2008 Jan; 93(1):120-3. PubMed ID: 18166795
[TBL] [Abstract][Full Text] [Related]
14. An immunohistochemical study of the bone marrow lesions of systemic mastocytosis: expression of stem cell factor by lesional mast cells.
Akin C; Jaffe ES; Raffeld M; Kirshenbaum AS; Daley T; Noel P; Metcalfe DD
Am J Clin Pathol; 2002 Aug; 118(2):242-7. PubMed ID: 12162685
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic criteria and classification of mastocytosis: a consensus proposal.
Valent P; Horny HP; Escribano L; Longley BJ; Li CY; Schwartz LB; Marone G; Nuñez R; Akin C; Sotlar K; Sperr WR; Wolff K; Brunning RD; Parwaresch RM; Austen KF; Lennert K; Metcalfe DD; Vardiman JW; Bennett JM
Leuk Res; 2001 Jul; 25(7):603-25. PubMed ID: 11377686
[TBL] [Abstract][Full Text] [Related]
16. Clinical Impact of Skin Lesions in Mastocytosis: A Multicenter Study of the European Competence Network on Mastocytosis.
Aberer E; Sperr WR; Bretterklieber A; Avian A; Hadzijusufovic E; Kluin-Nelemans HC; Oude Elberink H; van Anrooij B; Niedoszytko M; Lange M; Górska A; Elena C; Brazzelli V; Belloni Fortina A; Caroppo F; Hartmann K; Illerhaus A; Reiter A; Jawhar M; Bonadonna P; Zanotti R; Triggiani M; Parente R; Gotlib J; Doubek M; von Bubnoff N; Fuchs D; Sabato V; Brockow K; Jäkel N; Panse J; Valent P
J Invest Dermatol; 2021 Jul; 141(7):1719-1727. PubMed ID: 33581142
[TBL] [Abstract][Full Text] [Related]
17. Bone marrow involvement in cutaneous mastocytosis.
Fearfield LA; Francis N; Henry K; Costello C; Bunker CB
Br J Dermatol; 2001 Mar; 144(3):561-6. PubMed ID: 11260015
[TBL] [Abstract][Full Text] [Related]
18. Controversies in Allergy: Is a Bone Marrow Biopsy Optional or Essential in the Evaluation of the Patient with a Suspected Mast Cell Disorder?
Greenberger PA; Metcalfe DD
J Allergy Clin Immunol Pract; 2019 Apr; 7(4):1134-1138. PubMed ID: 30630762
[No Abstract] [Full Text] [Related]
19. Bone marrow tryptase as a possible diagnostic criterion for adult systemic mastocytosis.
Bulai Livideanu C; Apoil PA; Lepage B; Eischen M; Laurent C; Laharrague P; Lamant L; Tournier E; Tavitian S; Pouplard C; Recher C; Laroche M; Mailhol C; Dubreuil P; Hermine O; Blancher A; Paul C
Clin Exp Allergy; 2016 Jan; 46(1):133-41. PubMed ID: 26767494
[TBL] [Abstract][Full Text] [Related]
20. Imatinib mesylate in the treatment of systemic mastocytosis: a phase II trial.
Droogendijk HJ; Kluin-Nelemans HJ; van Doormaal JJ; Oranje AP; van de Loosdrecht AA; van Daele PL
Cancer; 2006 Jul; 107(2):345-51. PubMed ID: 16779792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
